BILLEV PHARMA ApS: Financial statements 2013
CVR: 81814813
Source: annual report 2013, Danish Business Authority
01/05/2012 – 30/04/2013
BILLEV PHARMA ApS (CVR 81814813) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 9,417,221 and a net result of DKK 727,552. Equity in the 2013 report amounted to DKK 2,441,229. The solvency ratio was 57%.
- Gross Profit
- DKK 9,417,221
- Profit/Loss
- DKK 727,552
- Equity
- DKK 2,441,229
- Total Assets
- DKK 4,285,026
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout BILLEV PHARMA ApS
BILLEV PHARMA ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 1977. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Anja Wencke van Arkens and Ulrikke Lynge Jensen. The company is owned by VAN ARKENS HOLDING ApS and UL JENSEN HOLDING ApS. The company has 15 employees (2018). In 2026, the company reported a gross profit of DKK 38,801,270 and a net result of DKK 10,205,639 compared with DKK 6,143,854 the year before. Equity in the 2026 report amounted to DKK 10,525,639.